Search

MSK medical oncologist Shanu Modi is the lead author of a new paper detailing the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. Results from this study were also presented at the San Antonio Breast Cancer Symposium.

… Wednesday, December 11, 2019 Summary A new study in the New England Journal of Medicine details the results from a phase II trial of a breast cancer drug called trastuzumab deruxtecan or DS-8201a. MSK medical oncologist Shanu Modi is the lead author of the paper, which was also presented at the San Antonio

Researchers have discovered a simple way to keep stem cells in a more flexible state for research and potential treatments.

… Thursday, June 27, 2019 Summary Stem cells that are pluripotent can develop into any cell type. These stem cells are easier to work with in their earlier naive state of pluripotency. Researchers have discovered that a commonly used fat-free culture medium can shift human stem cells closer to this naive

Up to 20 percent of people over the age of 70 have clonal hematopoiesis of indeterminate potential (CHIP), a condition that carries twice the risk of coronary heart disease and ischemic stroke, and worse outcomes after heart failure — independent of traditional cardiovascular risk factors.

… Tuesday, October 8, 2019 Up to 20 percent of people over the age of 70 have clonal hematopoiesis of indeterminate potential (CHIP), a condition that carries twice the risk of coronary heart disease and ischemic stroke, and worse outcomes after heart failure — independent of traditional cardiovascular

在 70 岁以上的人群中，高达 20% 的人有不确定潜能的克隆性造血 (CHIP)，这种情况会带来双倍冠心病和缺血性中风风险，并且导致心力衰竭后预后更差 — 无论传统的心血管风险因素如何。

… Tuesday, October 8, 2019 在 70 岁以上的人群中，高达 20% 的人有不确定潜能的克隆性造血 (CHIP)，这种情况会带来双倍冠心病和缺血性中风风险，并且导致心力衰竭后预后更差 — 无论传统的心血管风险因素如何。 该状况包括由造血干细胞中的体细胞突变引起的外周血突变白细胞。随着人口老龄化的增长，越来越多 CHIP 患者将前往心血管医生处就诊。 就使用 CHIP 筛查、评估和管理患者的最佳方法，仍存在一些疑问。我们和其他癌症研究中心的同事们一起，最近在 《美国心脏病学会杂志》 上发表了一篇论文。我们在论文中对 CHIP 进行了说明，回顾了一些临床问题，为 CHIP 患者的心血管风险管理提供了一些合理化建议

… Fellowship(s) Croucher Foundation Fellowship (2025-2026) Varmus Scholar (2024-2026) Education BS, UC San Diego; Cancer Biology Degree BS Mentor The Benjamin Greenbaum Lab Start Year 2023 Email [email protected]

The Patient and Family Advisory Council for Quality at Memorial Sloan Kettering Cancer Center (MSK) is a partnership of current and former patients, family members, and caregivers, along with clinical and administrative staff who work together to integrate the patient experience into all aspects of care at MSK. Council members use their powerful perspectives to make meaningful, patient-centered change that supports MSK’s mission of ending cancer for life.

… About PFACQ The Patient and Family Advisory Council for Quality at Memorial Sloan Kettering Cancer Center (MSK) is a partnership of current and former patients, family members, and caregivers, along with clinical and administrative staff who work together to integrate the patient experience into all

El PFACQ brinda a los pacientes y cuidadores la posibilidad de que se escuchen sus voces.

… Fundado en el año 2015, el Consejo Asesor de Calidad para Pacientes y Familias (PFACQ) de MSK es una asociación de pacientes actuales y anteriores, familiares, cuidadores, y personal clínico y administrativo. Para que cada paciente, familiar y cuidador reciba una atención oncológica de vanguardia que

… Job Title Senior Research Scientist Education Yale University Degree PhD Mentor Maria Jasin Email [email protected] Lab Phone 212-639-8384

… Job Title Program Manager

… Omni-ATAC: an improved ATAC-seq protocol for chromatin accessibility profiling in cells or tissues with reduced mitochondria DNA contamination and substantial improvement of signal-to-background ratio. It can be used to examine the regulatory landscape of chromatin. Reference: Corces, M.R., et al., An